Squarepoint’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-71,176
| Closed | -$1.8M | – | 2821 |
|
|
2024
Q4 | $1.8M | Sell |
71,176
-2,834
| -4% | -$71.6K | ﹤0.01% | 1223 |
|
|
2024
Q3 | $2.52M | Sell |
74,010
-88,997
| -55% | -$3.03M | ﹤0.01% | 1034 |
|
|
2024
Q2 | $6.03M | Buy |
163,007
+54,517
| +50% | +$2.02M | 0.01% | 620 |
|
|
2024
Q1 | $4.55M | Buy |
108,490
+90,936
| +518% | +$3.82M | 0.01% | 729 |
|
|
2023
Q4 | $696K | Buy |
+17,554
| New | +$696K | ﹤0.01% | 1524 |
|
|
2023
Q3 | – | Sell |
-11,719
| Closed | -$398K | – | 2508 |
|
|
2023
Q2 | $398K | Buy |
+11,719
| New | +$398K | ﹤0.01% | 1719 |
|
|
2023
Q1 | – | Sell |
-6,458
| Closed | -$288K | – | 2335 |
|
|
2022
Q4 | $288K | Buy |
+6,458
| New | +$288K | ﹤0.01% | 1720 |
|
|
2022
Q3 | – | Sell |
-78,345
| Closed | -$2.11M | – | 2127 |
|
|
2022
Q2 | $2.11M | Buy |
+78,345
| New | +$2.11M | 0.01% | 726 |
|
|
2022
Q1 | – | Sell |
-20,604
| Closed | -$796K | – | 2306 |
|
|
2021
Q4 | $796K | Buy |
20,604
+10,605
| +106% | +$410K | ﹤0.01% | 1341 |
|
|
2021
Q3 | $540K | Buy |
+9,999
| New | +$540K | ﹤0.01% | 1339 |
|
|
2021
Q2 | – | Sell |
-44,995
| Closed | -$927K | – | 2665 |
|
|
2021
Q1 | $927K | Sell |
44,995
-69,769
| -61% | -$1.44M | 0.01% | 1135 |
|
|
2020
Q4 | $2.01M | Buy |
114,764
+81,382
| +244% | +$1.43M | 0.02% | 751 |
|
|
2020
Q3 | $495K | Buy |
+33,382
| New | +$495K | 0.01% | 1356 |
|
|
2019
Q2 | – | Sell |
-12,130
| Closed | -$60K | – | 2330 |
|
|
2019
Q1 | $60K | Buy |
12,130
+8,052
| +197% | +$39.8K | ﹤0.01% | 2018 |
|
|
2018
Q4 | $12K | Sell |
4,078
-12,926
| -76% | -$38K | ﹤0.01% | 1869 |
|
|
2018
Q3 | $115K | Buy |
17,004
+7,421
| +77% | +$50.2K | ﹤0.01% | 1867 |
|
|
2018
Q2 | $72K | Buy |
+9,583
| New | +$72K | ﹤0.01% | 1671 |
|
|
2018
Q1 | – | Sell |
-2,007
| Closed | -$85K | – | 1733 |
|
|
2017
Q4 | $85K | Sell |
2,007
-477
| -19% | -$20.2K | ﹤0.01% | 1969 |
|
|
2017
Q3 | $107K | Buy |
+2,484
| New | +$107K | ﹤0.01% | 1487 |
|
|
2017
Q1 | – | Sell |
-3,697
| Closed | -$196K | – | 1553 |
|
|
2016
Q4 | $196K | Sell |
3,697
-4,503
| -55% | -$239K | 0.01% | 1447 |
|
|
2016
Q3 | $497K | Buy |
8,200
+7,487
| +1,050% | +$454K | 0.03% | 564 |
|
|
2016
Q2 | $47K | Sell |
713
-4,447
| -86% | -$293K | ﹤0.01% | 1031 |
|
|
2016
Q1 | $293K | Buy |
+5,160
| New | +$293K | 0.02% | 838 |
|